Melanoma Research Foundation
S

Systemic Therapies for Melanoma and Immune Related Adverse Effects (irAEs)

By Melanoma Research Foundation FEATURING Sunandana Chandra
By Melanoma Research Foundation FEATURING Sunandana Chandra
12 views
October 3, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Melanoma Research Foundation

Providence Saint John’s Cancer Center Patient and Caregiver Symposium

Sat, Oct 26, 2024
17:12
UNC Lineberger Comprehensive Cancer Center

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

Feat. A. Faso, B. Patel, K. Chen
20:09
Scripps Health

Dysplastic Nevi: Navigating the Risk Landscape

Feat. B. Kelley
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
35:23
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

Feat. S. Patel
15:19
Alberto Zambelli

Current Recommendations on Managing GI Adverse Reactions Associated …

12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
09:00
AAD 2024

AAD 2024 Insights: What's New In Nail Tumors

Feat. J. Dominguez-Cherit
22:58
Tarek Haykal

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

27:38
Oncology Data Advisor

Sun Safety and Melanoma Awareness: Expert Tips on Preventing Sun Dam…

Feat. T. Knight, M. Hadfield
09:26
Oncology Data Advisor

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Feat. M. Hadfield
11:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, …

Feat. D. Johnson
25:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Insights in Melanoma"

Feat. O. Hamid
14:42
Jeff Yorio

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

09:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Ou…

Feat. H. Tawbi
20:41
Cleveland Clinic Taussig Cancer Institute

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Feat. R. Unwala
28:32
West Virginia State Rheumatology Society

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

Feat. J. Bustamante
03:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib …

Feat. A. Hauschild
18:28
Vanderbilt University Medical Center (VUMC)

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Feat. D. Johnson
26:06
Kathryn Post

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Feat. J. Hutchinson